 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.

Market Cap	$59.47M
Volume (M)	200.00
52-Wk High	$3.51
52-Wk Low	$3.51

Current Price	$3.51
Prev Close	$3.51
Open	$3.51
Dividend Yield	0.00%
50-Day Moving Average	$3.51
Beta	0.00
Avg. Volume	0.00
PE Ratio	-4.80

52-Week High	$3.51
52-Week Low	$3.51
Market Capitalization	$59.47M
EPS	-$0.3348
Price to Book	-923.68
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-5.06

HRPMF Herantis Pharma OYJ

About

Feed

News

Fundamentals